Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing DisciplineWendy Landier, Melissa M. Hudson, Julie Blatt et al.|Journal of Clinical Oncology|2004Cited by 709
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout diseaseKiersten Ricci, Denise M. Adams, Adrienne M. Hammill et al.|Pediatric Blood & Cancer|2019Cited by 126
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.David G. Poplack, David G. Johns, Stephen E. Sallan et al.|PubMed|1981Cited by 87
Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United StatesBryan A. Sisk, Katherine A. King, Whitney Eng et al.|Pediatric Blood & Cancer|2025Cited by 1